Literature DB >> 2542603

Identification of a promoter region for 3.6-kilobase mRNA of hepatitis B virus and specific cellular binding protein.

K Yaginuma1, K Koike.   

Abstract

The promoter region for transcription of the 3.6-kilobase mRNA of hepatitis B virus was identified by the chloramphenicol acetyltransferase assay by using HuH-7 hepatoma cells and was found to function directly in virus production by way of the transient expression system of HBV. The 5'-upstream sequence from nucleotides 1573 to 1657 (the transcription start site) was indispensable for promoter function, while the AT-rich sequence (from nucleotides 1581 to 1604) containing a directly repeated sequence TGTT connecting the same flanking sequence PyAAAGAC (where Py is a pyrimidine) at both sides was an essential element within this promoter region. A specific cellular factor which interacted with the essential element was detected in the HuH-7 cell extract. A similar binding factor was also observed in HepG2 and huH2-2 hepatoma cells. This factor may thus be responsible for regulating 3.6-kilobase mRNA, pregenome RNA transcription, or both.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542603      PMCID: PMC250844     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.

Authors:  R P Beasley; L Y Hwang; C C Lin; C S Chien
Journal:  Lancet       Date:  1981-11-21       Impact factor: 79.321

2.  Transcription of hepatitis B virus by RNA polymerase II.

Authors:  L B Rall; D N Standring; O Laub; W J Rutter
Journal:  Mol Cell Biol       Date:  1983-10       Impact factor: 4.272

3.  Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence.

Authors:  F Galibert; T N Chen; E Mandart
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

4.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

5.  Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

Authors:  H Nakabayashi; K Taketa; K Miyano; T Yamane; J Sato
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

6.  Signals regulating hepatitis B surface antigen transcription.

Authors:  R Cattaneo; H Will; N Hernandez; H Schaller
Journal:  Nature       Date:  1983 Sep 22-28       Impact factor: 49.962

7.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

Authors:  B B Knowles; C C Howe; D P Aden
Journal:  Science       Date:  1980-07-25       Impact factor: 47.728

8.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line.

Authors:  C M Chang; K S Jeng; C P Hu; S J Lo; T S Su; L P Ting; C K Chou; S H Han; E Pfaff; J Salfeld
Journal:  EMBO J       Date:  1987-03       Impact factor: 11.598

View more
  18 in total

1.  Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II.

Authors:  H Ishida; K Ueda; K Ohkawa; Y Kanazawa; A Hosui; F Nakanishi; E Mita; A Kasahara; Y Sasaki; M Hori; N Hayashi
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  A transcription initiation site for the hepatitis B virus X gene is directed by the promoter-binding protein.

Authors:  K Yaginuma; I Nakamura; S Takada; K Koike
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

3.  In vivo regulation of hepatitis B virus replication by peroxisome proliferators.

Authors:  L G Guidotti; C M Eggers; A K Raney; S Y Chi; J M Peters; F J Gonzalez; A McLachlan
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication.

Authors:  V E Buckwold; Z Xu; M Chen; T S Yen; J H Ou
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis.

Authors:  K Hasegawa; J Huang; S A Rogers; H E Blum; T J Liang
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

6.  Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein.

Authors:  M López-Cabrera; J Letovsky; K Q Hu; A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

Review 7.  Core promoter: a critical region where the hepatitis B virus makes decisions.

Authors:  Jorge Quarleri
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

8.  Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor.

Authors:  A K Raney; H B Le; A McLachlan
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  Characterization of functional Sp1 transcription factor binding sites in the hepatitis B virus nucleocapsid promoter.

Authors:  P Zhang; A K Raney; A McLachlan
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  Identification and cloning of a novel heterogeneous nuclear ribonucleoprotein C-like protein that functions as a transcriptional activator of the hepatitis B virus enhancer II.

Authors:  N Tay; S H Chan; E C Ren
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.